Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[First-pass effect of dauricine]

Y T Gui1, Z H Du, F D Zeng

  • 1Department of Clinical Pharmacology, Tongji Medical University, Hankou, China.

Zhongguo Yao Li Xue Bao = Acta Pharmacologica Sinica
|March 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Clinical investigation of in-stent restenosis following self-expanding intracranial artery stenting].

Zhonghua nei ke za zhi·2026
Same author

[Chinese guidelines on clinical application of antiphospholipid antibodies (2026 edition)].

Zhonghua nei ke za zhi·2026
Same author

[Analysis of perioperative complications of flow-diverter devices in the treatment of unruptured intracranial aneurysms].

Zhonghua wai ke za zhi [Chinese journal of surgery]·2024
Same author

[Gastric hamartomatous inverted polyps: a clinicopathological analysis of five cases].

Zhonghua bing li xue za zhi = Chinese journal of pathology·2024
Same author

Characteristics of atmospheric ice nucleating particles over East Antarctica retrieved from the surface snow.

The Science of the total environment·2023
Same author

[Current practices in the harmonisation of autoantibodies test].

Zhonghua nei ke za zhi·2023
Same journal

Preparation and dissolution property of ipriflavone solid dispersion.

Zhongguo yao li xue bao = Acta pharmacologica Sinica·2001
Same journal

Pharmacokinetics of sustained-release capsule of 5-isosorbide mononitrate in 20 healthy Chinese young men.

Zhongguo yao li xue bao = Acta pharmacologica Sinica·2001
Same journal

Platelet activating factor-induced P-selectin expression in platelets and its related signal transduction.

Zhongguo yao li xue bao = Acta pharmacologica Sinica·2001
Same journal

Fibrinogenolytic properties of natrahagin (a proteinase from cobra venom) and its effect on human platelet aggregation.

Zhongguo yao li xue bao = Acta pharmacologica Sinica·2001
Same journal

Ginkgolide A, B, and huperzine A inhibit nitric oxide production from rat C6 and human BT325 glioma cells.

Zhongguo yao li xue bao = Acta pharmacologica Sinica·2001
Same journal

Inhibitory effect of MAP kinase antisense oligonucleotide on angiotensin II-induced c-myc gene expression and proliferation of rat cardiac fibroblast.

Zhongguo yao li xue bao = Acta pharmacologica Sinica·2001
See all related articles

Dauricine exhibits a significant first-pass effect, impacting its plasma concentration and antiarrhythmic efficacy. This effect is dose-dependent, influencing therapeutic potential.

Area of Science:

  • Pharmacology
  • Cardiovascular Physiology

Context:

  • The first-pass effect significantly influences drug bioavailability and efficacy.
  • Dauricine is a potential antiarrhythmic agent requiring pharmacokinetic evaluation.
  • Lidocaine serves as a comparator for first-pass effect studies.

Purpose:

  • To compare the first-pass effect of dauricine (Dau) with lidocaine (Lid).
  • To assess the impact of administration route on dauricine's pharmacokinetic profile.
  • To determine the dose-dependency of dauricine's first-pass effect.

Summary:

  • Dauricine and lidocaine were evaluated in rats and rabbits by measuring ventricular fibrillation threshold (VFT) and plasma dauricine concentration.
  • Intravenous (IV) infusion routes (ear vein vs. mesenteric vein) affected dauricine plasma levels, with ear vein infusion yielding higher concentrations.

Related Experiment Videos

  • Dauricine demonstrated a notable, dose-dependent first-pass effect, indicated by nonlinear increases in AUC with higher doses.

    • Impact:

    • Understanding dauricine's first-pass effect is crucial for optimizing its therapeutic use.
    • The study highlights the importance of administration route in dauricine pharmacokinetics.
    • Findings provide insights into dauricine's potential as an antiarrhythmic drug and inform future clinical development.